BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  ASCO15: ImmunoGen’s Mirvetuximab Soravtansine (IMGN853) Demonstrates Notable Single Agent Activity For Patients With Platinum-Resistant Ovarian Cancer

  June 1, 2015

   · 

  6 min read
• Drug Development

  Pharmacyclics Release: Ibrutinib (IMBRUVICA) Phase Ib/II Data Show Promise In Patients With Chronic Graft-Versus-Host-Disease

  June 1, 2015

   · 

  12 min read
• Drug Development

  Amgen Initiates Phase 3 Study Evaluating Once-Weekly Kyprolis® (carfilzomib) in Patients With Relapsed And Refractory Multiple Myeloma

  June 1, 2015

   · 

  17 min read
• Drug Development

  Pharmacyclics Release: Analysis Of Phase III RESONATE Data Shows Adherence To The Recommended 420mg Dose Of IMBRUVICA (Ibrutinib) Results In Improved Efficacy Benefits In Patients With Chronic Lymphocytic Leukemia

  June 1, 2015

   · 

  14 min read
• Drug Development

  ASCO15: Clovis Oncology’s Rociletinib (CO-1686) Phase II Study Results Demonstrate Consistent And Promising Clinical Activity And Disease Control In Very Advanced Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC

  June 1, 2015

   · 

  11 min read
• Drug Development

  ASCO15: AbbVie Presents Phase 2 Results From Study Of Investigational Medicine Veliparib In Patients With Non-Small Cell Lung Cancer At The American Society Of Clinical Oncology Annual Meeting

  June 1, 2015

   · 

  8 min read
• Drug Development

  ASCO15: Eisai Company’s Eribulin Extends Survival in Patients With Rare Cancers

  June 1, 2015

   · 

  7 min read
• Drug Development

  ASCO15: Results From Phase 2 Study Of Lenvatinib When Combined With Everolimus In Metastatic Renal Cell Carcinoma To Be Presented In Oral Session At ASCO

  June 1, 2015

   · 

  9 min read
• Drug Development

  ASCO15: Esperance Pharmaceuticals, Inc. Reports Positive EP-100 Phase Ll Results In Ovarian Cancer At 2015 ASCO Annual Meeting

  June 1, 2015

   · 

  3 min read
• Business

  AMRI And HarkerBIO Ink Collaborative Agreement In Buffalo, N.Y.

  June 1, 2015

   · 

  4 min read